Teladoc Health Inc
TDOC7.455USD
-0.155-2.04%
Close 01/09, 16:00（ET）Quotes delayed by 15 min
1.32BMarket Cap
LossP/E TTM
More Details of Teladoc Health Inc Company
Teladoc Health, Inc. provides virtual healthcare services. Its segments include Teladoc Health Integrated Care (Integrated Care) and BetterHelp. Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed on a B2B basis. BetterHelp segment includes direct-to-consumer mental health platform. The online counseling and therapy services are provided via its network of over 35,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs. Its Telecare brand is a tech-enabled provider of specialist and allied health care via virtual delivery.
Teladoc Health Inc Info
Ticker SymbolTDOC
Company nameTeladoc Health Inc
IPO dateJul 01, 2015
CEODivita (Charles III)
Number of employees5500
Security typeOrdinary Share
Fiscal year-endJul 01
Address155 E 44Th Street
CityNEW YORK
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code10017
Phone12036352002
Websitehttps://www.teladochealth.com/
Ticker SymbolTDOC
IPO dateJul 01, 2015
CEODivita (Charles III)
Company Executives of Teladoc Health Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Charles (Chuck) Divita, III
Mr. Charles (Chuck) Divita, III
Chief Executive Officer, Director
Chief Executive Officer, Director
201.04K
+22022.00%
Mr. Adam C. Vandervoort, J.D.
Mr. Adam C. Vandervoort, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
80.73K
+5553.00%
Ms. Kelly Bliss
Ms. Kelly Bliss
President, U.S. Group Health
President, U.S. Group Health
60.05K
+4953.00%
Ms. Sandra L. Fenwick
Ms. Sandra L. Fenwick
Independent Director
Independent Director
40.43K
--
Mr. David L. Shedlarz
Mr. David L. Shedlarz
Independent Director
Independent Director
32.28K
+17467.00%
Mr. Kenneth H. (Ken) Paulus
Mr. Kenneth H. (Ken) Paulus
Independent Director
Independent Director
10.00K
+10000.00%
Dr. Mark Douglas Smith, M.D.
Dr. Mark Douglas Smith, M.D.
Independent Director
Independent Director
8.36K
--
Mr. Thomas G. Mckinley
Mr. Thomas G. Mckinley
Independent Director
Independent Director
--
--
Mr. David B. Snow, Jr.
Mr. David B. Snow, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Catherine A. Jacobson
Ms. Catherine A. Jacobson
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Charles (Chuck) Divita, III
Mr. Charles (Chuck) Divita, III
Chief Executive Officer, Director
Chief Executive Officer, Director
201.04K
+22022.00%
Mr. Adam C. Vandervoort, J.D.
Mr. Adam C. Vandervoort, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
80.73K
+5553.00%
Ms. Kelly Bliss
Ms. Kelly Bliss
President, U.S. Group Health
President, U.S. Group Health
60.05K
+4953.00%
Ms. Sandra L. Fenwick
Ms. Sandra L. Fenwick
Independent Director
Independent Director
40.43K
--
Mr. David L. Shedlarz
Mr. David L. Shedlarz
Independent Director
Independent Director
32.28K
+17467.00%
Mr. Kenneth H. (Ken) Paulus
Mr. Kenneth H. (Ken) Paulus
Independent Director
Independent Director
10.00K
+10000.00%
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q3
FY2022Q2
By BusinessUSD
Name
Revenue
Proportion
Access Fees Revenue
520.91M
83.15%
Other
105.53M
16.85%
By RegionUSD
Name
Revenue
Proportion
United States
509.77M
81.38%
International
116.67M
18.62%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Access Fees Revenue
520.91M
83.15%
Other
105.53M
16.85%
Shareholding Stats
Updated: Mon, Dec 15
Updated: Mon, Dec 15
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
12.29%
BlackRock Institutional Trust Company, N.A.
6.91%
Renaissance Technologies LLC
4.61%
Dimensional Fund Advisors, L.P.
3.88%
Point72 Asset Management, L.P.
3.25%
Other
69.06%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
12.29%
BlackRock Institutional Trust Company, N.A.
6.91%
Renaissance Technologies LLC
4.61%
Dimensional Fund Advisors, L.P.
3.88%
Point72 Asset Management, L.P.
3.25%
Other
69.06%
Shareholder Types
Shareholders
Proportion
Investment Advisor
31.28%
Investment Advisor/Hedge Fund
19.60%
Hedge Fund
14.46%
Research Firm
5.08%
Individual Investor
1.13%
Bank and Trust
0.79%
Pension Fund
0.54%
Family Office
0.14%
Sovereign Wealth Fund
0.10%
Other
26.88%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
925
127.72M
72.01%
-41.66M
2025Q3
959
134.32M
75.74%
-32.25M
2025Q2
998
134.63M
76.20%
-42.03M
2025Q1
1041
132.44M
75.49%
-42.98M
2024Q4
1063
134.61M
77.51%
-37.55M
2024Q3
1133
134.94M
78.45%
-32.89M
2024Q2
1195
142.47M
83.22%
-14.73M
2024Q1
1317
130.90M
77.27%
-19.41M
2023Q4
1432
129.36M
77.56%
-18.52M
2023Q3
1538
125.63M
75.92%
-38.92M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
21.80M
12.29%
+891.73K
+4.27%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
12.25M
6.91%
+41.01K
+0.34%
Sep 30, 2025
Renaissance Technologies LLC
8.18M
4.61%
+855.30K
+11.68%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
6.89M
3.88%
+1.33M
+23.82%
Sep 30, 2025
Point72 Asset Management, L.P.
5.76M
3.25%
-2.08M
-26.49%
Sep 30, 2025
State Street Investment Management (US)
4.66M
2.63%
-318.88K
-6.40%
Sep 30, 2025
Geode Capital Management, L.L.C.
4.17M
2.35%
+19.72K
+0.48%
Sep 30, 2025
Morgan Stanley & Co. LLC
3.03M
1.71%
+1.61M
+114.24%
Sep 30, 2025
Two Sigma Investments, LP
2.57M
1.45%
-2.45M
-48.83%
Sep 30, 2025
Charles Schwab Investment Management, Inc.
2.54M
1.43%
-99.28K
-3.76%
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Global X HealthTech ETF
1.27%
First Trust Indxx Metaverse ETF
1.17%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.65%
Principal U.S. Small-Cap ETF
0.46%
Langar Global HealthTech ETF
0.38%
First Trust Small Cap Value AlphaDEX Fund
0.29%
iShares U.S. Healthcare Providers ETF
0.24%
Optimize Strategy Index ETF
0.24%
Fidelity Enhanced Small Cap ETF
0.2%
State Street SPDR S&P Kensho New Econ Comp ETF
0.18%
View more
Global X HealthTech ETF
Proportion1.27%
First Trust Indxx Metaverse ETF
Proportion1.17%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion0.65%
Principal U.S. Small-Cap ETF
Proportion0.46%
Langar Global HealthTech ETF
Proportion0.38%
First Trust Small Cap Value AlphaDEX Fund
Proportion0.29%
iShares U.S. Healthcare Providers ETF
Proportion0.24%
Optimize Strategy Index ETF
Proportion0.24%
Fidelity Enhanced Small Cap ETF
Proportion0.2%
State Street SPDR S&P Kensho New Econ Comp ETF
Proportion0.18%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Teladoc Health Inc?
The top five shareholders of Teladoc Health Inc are:
The Vanguard Group, Inc. holds 21.80M shares, accounting for 12.29% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 12.25M shares, accounting for 6.91% of the total shares.
Renaissance Technologies LLC holds 8.18M shares, accounting for 4.61% of the total shares.
Dimensional Fund Advisors, L.P. holds 6.89M shares, accounting for 3.88% of the total shares.
Point72 Asset Management, L.P. holds 5.76M shares, accounting for 3.25% of the total shares.
The Vanguard Group, Inc. holds 21.80M shares, accounting for 12.29% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 12.25M shares, accounting for 6.91% of the total shares.
Renaissance Technologies LLC holds 8.18M shares, accounting for 4.61% of the total shares.
Dimensional Fund Advisors, L.P. holds 6.89M shares, accounting for 3.88% of the total shares.
Point72 Asset Management, L.P. holds 5.76M shares, accounting for 3.25% of the total shares.
What are the top three shareholder types of Teladoc Health Inc?
The top three shareholder types of Teladoc Health Inc are:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
Renaissance Technologies LLC
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
Renaissance Technologies LLC
How many institutions hold shares of Teladoc Health Inc (TDOC)?
As of 2025Q4, 925 institutions hold shares of Teladoc Health Inc, with a combined market value of approximately 127.72M, accounting for 72.01% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -3.72%.
What is the biggest source of revenue for Teladoc Health Inc?
In FY2025Q3, the Access Fees Revenue business generated the highest revenue for Teladoc Health Inc, amounting to 520.91M and accounting for 83.15% of total revenue.
